Home › Funds › NEXT CENTURY GROWTH INVESTORS LLC › MIRM

NEXT CENTURY GROWTH INVESTORS LLC position in MIRM

MIRUM PHARMACEUTICALS INC · Health Care

NEXT CENTURY GROWTH INVESTORS LLC reported holding 311,609 shares of MIRM (MIRUM PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$26.6M, representing 1.70% of its reported portfolio and ranking #18 among its reported holdings. NEXT CENTURY GROWTH INVESTORS LLC has disclosed MIRM holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

Latest position (Q3 2026)311.61K sh
Reported value held$26.64M
Portfolio Weight1.70%
First reportedQ3 2024
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How NEXT CENTURY GROWTH INVESTORS LLC's MIRM position evolved

NEXT CENTURY GROWTH INVESTORS LLC first disclosed a stake in MIRM in Q3 2024 at 164,371 shares (US$6.4M). The position peaked in Q2 2026 at 420,213 shares, worth US$49.2M. Across 9 filings, NEXT CENTURY GROWTH INVESTORS LLC increased the stake 5 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 311,609 shares valued at US$26.6M — a reduction of -108,604 shares quarter over quarter.. Notable position changes include a 90% increase in Q3 2025 (shares rose 8% over the following quarter), a 26% trim in Q3 2026 (shares rose 10% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 164.37K $6.41M New
Q4 2024 164.25K $6.79M Hold
Q1 2025 195.34K $8.80M Add
Q2 2025 190.32K $9.69M Reduce
Q3 2025 360.93K $26.46M Add
Q4 2025 368.04K $29.07M Add
Q1 2026 385.54K $35.62M Add
Q2 2026 420.21K $49.19M Add
Q3 2026 311.61K $26.64M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MIRM and 13F data

MIRM (MIRUM PHARMACEUTICALS INC) is a Health Care company. 49 other funds we track also report a position in MIRM — the largest reported positions include Frazier Life Sciences Management, L.P. (US$899.1M), EVENTIDE ASSET MANAGEMENT, LLC (US$146.2M), TANG CAPITAL MANAGEMENT LLC (US$144.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MIRM

All MIRM fund holders →

FAQ

How long has NEXT CENTURY GROWTH INVESTORS LLC held MIRM?

NEXT CENTURY GROWTH INVESTORS LLC has disclosed MIRM holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

What is NEXT CENTURY GROWTH INVESTORS LLC's current position in MIRM?

As of Q3 2026, NEXT CENTURY GROWTH INVESTORS LLC holds 311.61K shares of MIRM (MIRUM PHARMACEUTICALS INC), valued at $26.64M, representing 1.70% of its reported portfolio and ranking #18.

Has NEXT CENTURY GROWTH INVESTORS LLC been buying or selling MIRM?

In the latest 13F filing (Q3 2026), NEXT CENTURY GROWTH INVESTORS LLC reduced its position in MIRM. The position peaked in Q2 2026 at 420.21K shares.

Which other funds hold MIRM?

Other major institutional holders of MIRM include Frazier Life Sciences Management, L.P., EVENTIDE ASSET MANAGEMENT, LLC, TANG CAPITAL MANAGEMENT LLC, among 49 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.